HELZ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.346300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.286800E-01
Normal-vs-Stage2
6.246100E-02
Normal-vs-Stage3
1.059850E-01
Normal-vs-Stage4
4.531200E-01
Stage1-vs-Stage2
1.210560E-01
Stage1-vs-Stage3
1.035180E-01
Stage1-vs-Stage4
6.491000E-01
Stage2-vs-Stage3
2.478200E-01
Stage2-vs-Stage4
5.586200E-01
Stage3-vs-Stage4
2.592400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.752200E-02
Normal-vs-AfricanAmerican
4.718800E-01
Normal-vs-Asian
1.035350E-01
Caucasian-vs-AfricanAmerican
3.143800E-01
Caucasian-vs-Asian
4.715200E-01
AfricanAmerican-vs-Asian
2.576600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.058000E-02
Normal-vs-Female
9.338000E-02
Male-vs-Female
6.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.791200E-01
Normal-vs-Age(41-60Yrs)
2.806000E-01
Normal-vs-Age(61-80Yrs)
3.223600E-02
Normal-vs-Age(81-100Yrs)
3.650500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.986800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.462960E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.839900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.224200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.066410E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.172600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.748100E-02
Normal-vs-Daily Drinker
5.816800E-03
Normal-vs-Weekly Drinker
7.140000E-02
Normal-vs-Occasional Drinker
1.189800E-01
Normal-vs-Social Drinker
3.607400E-01
Non Drinker-vs-Daily Drinker
2.509000E-01
Non Drinker-vs-Weekly Drinker
8.227600E-01
Non Drinker-vs-Occasional Drinker
5.424200E-01
Non Drinker-vs-Social Drinker
1.721590E-01
Daily Drinker-vs-Weekly Drinker
4.474800E-01
Daily Drinker-vs-Occasional Drinker
8.617600E-02
Daily Drinker-vs-Social Drinker
4.288000E-02
Weekly Drinker-vs-Occasional Drinker
4.714000E-01
Weekly Drinker-vs-Social Drinker
1.988570E-01
Occasional Drinker-vs-Social Drinker
4.473400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.389380E-01
Normal-vs-Grade 2
8.399700E-02
Normal-vs-Grade 3
4.696500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.108600E-01
Grade 1-vs-Grade 3
9.951200E-01
Grade 1-vs-Grade 4
1.389380E-01
Grade 2-vs-Grade 3
2.211000E-01
Grade 2-vs-Grade 4
8.399700E-02
Grade 3-vs-Grade 4
4.696500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.862070E-02
Normal-vs-NonDiabetic
5.268200E-02
Diabetic-vs-NonDiabetic
2.549400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.085430E-01
Normal-vs-NoPancreatitis
4.208100E-02
Pancreatitis-vs-NoPancreatitis
9.211400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.507000E-01
Normal-vs-N1
5.489900E-02
N0-vs-N1
7.734000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.526200E-02
Normal-vs-TP53-NonMutant
3.421000E-01
TP53-Mutant-vs-TP53-NonMutant
2.231900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
